K
Knight Therapeutics Inc
TSX:GUD
Knight Therapeutics Inc
TSX:GUD
Price:
6.27
CAD
1.13%
Market Cap:
CA$619m
Relative Value
The Relative Value of one GUD stock under the Base Case scenario is hidden CAD. Compared to the current market price of 6.27 CAD, Knight Therapeutics Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GUD Relative Value
HIDDEN
Multiples Across Competitors
GUD Competitors Multiples
Knight Therapeutics Inc Competitors
Knight Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
K
|
Knight Therapeutics Inc
TSX:GUD
|
625m CAD | 1.5 | -178.9 | 13.4 | -51 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
943B USD | 14.4 | 45.6 | 30.8 | 32.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
582.6B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
262.8B CHF | 4.3 | 20.4 | 12 | 13.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.9B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
223.2B GBP | 5.1 | 29.2 | 16.2 | 22.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.4B USD | 4.4 | 15.8 | 9.8 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.9 | 8 | 9.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.3B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17.1 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
